Company Overview - Envoy Medical, Inc. is a hearing health company focused on fully implanted hearing devices, participating in the 37th Annual ROTH Conference from March 16-18, 2025 [1][2] Product Information - The Acclaim Cochlear Implant (Acclaim CI) is a first-of-its-kind fully implanted hearing device that utilizes a sensor to capture sound by leveraging the natural anatomy of the ear, rather than using a microphone [3] - The Acclaim CI is designed for adults with severe to profound sensorineural hearing loss, which is not adequately addressed by traditional hearing aids, and received Breakthrough Device Designation from the FDA in 2019 [4] - The Esteem Fully Implanted Active Middle Ear Implant (FI-AMEI) is the only FDA-approved fully implanted hearing device for adults with moderate to severe sensorineural hearing loss, providing 24/7 hearing capability without external components [5][6] Conference Participation - The CEO and CFO of Envoy Medical will hold one-on-one meetings with investors and analysts at the ROTH Conference to discuss recent events and provide updates [2]
Envoy Medical to Participate in the 37th Annual ROTH Conference